Hercules Capital, Inc. (HTGC) Stock Analysis
Range Bound setup
Financial Services · Asset Management
Hold if already holding. Not a fresh buy at $15.62, but acceptable to hold if already in. Reasons: Thin upside margin: 8.7%; Leverage penalty (D/E 1.1): -0.5.
Hercules Capital is an internally managed BDC providing senior secured loans to venture capital-backed technology and life sciences companies, with over $25B in commitments since inception. Revenue comes from interest income, exit fees, and warrant/equity appreciation across... Read more
Hold if already holding. Not a fresh buy at $15.62, but acceptable to hold if already in. Reasons: Thin upside margin: 8.7%; Leverage penalty (D/E 1.1): -0.5. Chart setup: RSI 53 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.
Passes 7/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 45d clear, semi cycle peak clear, materials cycle peak clear). Fails on death cross (50MA < 200MA). Suitability: aggressive.
Recent developments
updated 2026-06-15Recent Developments — Hercules Capital, Inc.
Latest news
- NEWS HTGC Investor Alert: Hercules Capital Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action — PR Newswire negative
- NEWS Why Hercules Capital (HTGC) Just Surged +1.99% — Key Levels Ahead 2026-05-20 - Dynamic Hedging - Newser — Newser positive
- NEWS Why Hercules Capital (HTGC) Just Surged +1.99% — Key Levels Ahead 2026-05-20 - Fear Greed Index - Newser — Newser positive
- NEWS Why Hercules Capital (HTGC) Just Surged +1.99% — Key Levels Ahead 2026-05-20 - Fear Greed Index - newser.com — newser.com neutral
- NEWS Hercules Capital, Inc. Common Stock (NY: HTGC - FinancialContent — FinancialContent neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProductApplication Software industry24%10-K Item 1A: '24.3% comprised investments in the "Application Software" industry'
- MEDIUMProductDrug Discovery & Development industry23%10-K Item 1A: '23.3% comprised investments in the "Drug Discovery & Development" industry'
- MEDIUMProductHealthcare Services, Other industry19%10-K Item 1A: '18.8% comprised investments in the "Healthcare Services, Other" industry'
Material Events(8-K, last 90d)
- 2026-05-04Item 5.02MEDIUMCFO Seth Meyer transitions to President effective May 18, 2026. Andrew Olson appointed as new CFO effective May 18, 2026. Clean handoff; no disagreement cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $15.62, but acceptable to hold if already in. Reasons: Thin upside margin: 8.7%; Leverage penalty (D/E 1.1): -0.5. Chart setup: RSI 53 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $16.84 (+7.8%), stop $14.90 (−4.8%), A.R:R 1.7:1. Score 6.1/10, moderate confidence.
Take-profit target: $16.84 (+8.6% upside). Target $16.84 (+7.8%), stop $14.90 (−4.8%), A.R:R 1.7:1. Stop-loss: $14.90.
Thin upside margin: 8.7%; Leverage penalty (D/E 1.1): -0.5; Below 200-MA, MA slope -1.7%/30d (confirmed downtrend).
Hercules Capital, Inc. trades at a P/E of 8.7 (forward 7.8). TrendMatrix value score: 7.7/10. Verdict: Hold.
15 analysts cover HTGC with a consensus score of 4.1/5. Average price target: $19.
What does Hercules Capital, Inc. do?Hercules Capital is an internally managed BDC providing senior secured loans to venture capital-backed technology and...
Hercules Capital is an internally managed BDC providing senior secured loans to venture capital-backed technology and life sciences companies, with over $25B in commitments since inception. Revenue comes from interest income, exit fees, and warrant/equity appreciation across 164+ portfolio companies. As an internally managed BDC, Hercules avoids external management fees.